Regions of apoprotein(a) of lipoprotein(a) [L,p(a)] exhibitstriking pr
imary sequence homology to the kringles of plasminogen. The kringles o
f plasminogen are lysine binding structures and mediate interactions o
f plasmin(ogen) with substrates and inhibitors. In the current study,
the lysine binding properties of Lp(a) have been compared to those of
plasminogen and isolated kringle 4 of plasminogen (K4). An analytical
assay was implemented to quantitate the interaction of kringle-contain
ing molecules with lysine-Sepharose beads. Radioiodinated ligands, Lp(
a), plasminogen, and K4, bound to the beads, and their interactions we
re inhibited by lysine analogues in a dose-dependent fashion. A series
of omega-aminocarboxylic acids inhibited Lp(a), plasminogen, and K4 b
inding to the lysine-Sepharose beads, but marked differences in the ef
fectiveness of these compounds were observed with each ligand. In this
series of compounds, 6-aminohexanoic acid was the most potent inhibit
or of binding to lysine-Sepharose for all three ligands. The pH had li
ttle effect on the inhibition of plasminogen binding by these compound
s. For Lp(a), a low pH caused a marked decrease in inhibition by the 5
-carbon and 4-carbon omega-amino acids. In addition, tranexamic acid w
as 750-fold more potent than lysine in inhibiting plasminogen and 55-f
old more potent for K4 binding to the beads. In contrast, the differen
tial potency of these compounds on Lp(a) binding was only 3-fold. Thes
e results suggest that the kringles of Lp(a) possess lysine binding fu
nctions which are similar, but not identical, to those of plasminogen
and its K4. To test this conclusion in a biological context, I-125-Lp(
a) and I-125-plasminogen binding to monocytoid cells and fibrin clots
was compared. The potency of tranexamic acid was much higher than that
of lysine for inhibiting plasminogen binding to cells and to fibrin c
lots. In contrast, the ratio of tranexamic acid to lysine efficacy was
less pronounced for Lp(a) binding to cells and to fibrin. Thus, Lp(a)
possesses lysine binding sites which can mediate its interaction with
cells and with fibrin, but the fine specificity of these sites in Lp(
a) and plasminogen is distinguishable.